The role of antiarrhythmic drugs in sudden cardiac death
Autor: | Brian F. Hoffman, Kenneth H. Dangman |
---|---|
Rok vydání: | 1986 |
Předmět: |
Fibrillation
medicine.medical_specialty business.industry Sodium Myocardial Infarction Action Potentials Coronary Disease Reentry medicine.disease Ion Channels Sudden cardiac death Death Sudden Dogs Internal medicine Ventricular Fibrillation Ventricular fibrillation Cardiology medicine Animals Calcium Anesthetics Local medicine.symptom Cardiology and Cardiovascular Medicine business Anti-Arrhythmia Agents |
Zdroj: | Journal of the American College of Cardiology. 8:104A-109A |
ISSN: | 0735-1097 |
DOI: | 10.1016/s0735-1097(86)80036-5 |
Popis: | Antiarrhythmic drugs may either decrease or increase the likelihood of ventricular fibrillation. Although reliable data suggest reasonable mechanisms for the antiarrhythmic action of several drugs, much less information is available to indicate the mechanisms by which drugs are arrhythmogenic. Antiarrhythmic action may result from suppression of precipitating events such as inappropriately timed premature impulses or runs of excessively rapid impulses and from modification of the conditions predisposing to random reentry. Increases in the likelihood of fibrillation may result from opposite effects on precipitating events or from drug-induced increase in the likelihood of random reentry. One factor that very likely is involved in the latter is the presence of local differences in the electrical activity of myocardial cells that cause significant local differences in the tonic and use-dependent actions of antiarrhythmic drugs. |
Databáze: | OpenAIRE |
Externí odkaz: |
načítá se...